Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
RTX Corporation closes the final stretch before its October 20 earnings print at $183.02, down another 2% on Tuesday, with options traders visibly more defensive and short sellers quietly adding to positions over the past month.
The most notable shift this week is in options positioning. The put/call ratio has moved to 0.88, running about one and a half standard deviations above its 20-day average of 0.80. That is not a panic reading, the 52-week high sits at 1.02, but the directional drift is clear: protective demand has been rising steadily since early October as the earnings date approaches. The PCR was down near 0.75 at the start of last month. It has climbed almost every week since.
Short interest reinforces the cautious tone, though the level itself is not alarming. Shorts have built a 30% position increase over the past month, with shares short reaching roughly 14.1 million, equal to about 1.05% of the free float. That remains a low absolute figure for a name of this size. The lending market is entirely untroubled: availability is effectively uncapped, with nearly 967 million shares available to borrow, and the cost to borrow, while up 38% on the week to 0.50%, is still trivially cheap in absolute terms. The short-score reading of 31.0 is steady and well below levels that would signal crowded positioning. The message from the lending market is that bears are nibbling, not piling in.
The Street's collective view has barely shifted since the previous note, but two actions from last week are worth grouping together. TD Cowen trimmed its target to $225 from $240 while holding its Buy rating, and Barclays initiated with an Overweight at $223, both on October 9. Those moves frame the near-term ceiling: even constructive analysts are anchoring their targets about 20 to 25% above the current price rather than pushing higher. The consensus remains solidly bullish, with 10 buys against 8 holds and a mean target of $228.83, implying roughly 25% upside from Tuesday's close. The analyst recommendation differential ranks in the 98th percentile of the ORTEX universe. The valuation picture is more mixed: the price-to-earnings multiple has compressed to about 23.7x over the past month, down roughly 1.8 turns over 30 days, reflecting the stock's slide rather than any downgrade of earnings expectations. EV/EBITDA has also moved lower, off about 0.4 turns over the same period.
The bull case centres on the Q2 momentum: 14% organic sales growth, a 14% EPS beat, and a $289 billion backlog that is 22% larger than a year ago. Raytheon's 18% organic growth and roughly $20 billion in awards underpin the defense side, while Collins Aerospace and Pratt & Whitney add commercial exposure. Bears point to supply chain bottlenecks in rocket motors, microelectronics, engine castings and forgings, GTF execution risk at Pratt, and potential tariff headwinds that could cap operating leverage. The two reads are not obviously reconcilable, which is precisely why the options market is bidding up protective cover into next Monday's release.
Earnings history adds context without offering much comfort to either camp. The Q2 print in late July produced a 9.2% single-day gain and a 10% five-day move, following a blowout beat. The prior event, in April, moved just 0.2% on the day before extending to a 12.4% five-day gain. The spread between those two outcomes is wide, and the current setup, stock down 7% over the past month and trading nearly $46 below the mean analyst target, suggests the market is pricing in at least some disappointment risk ahead of the October 20 open.
Institutional ownership is stable and heavily indexed: BlackRock, State Street and Vanguard collectively hold more than 22% of shares, with all three adding modestly in their most recent reported periods. There is no activist presence on the register. No open-market insider buying appears in the recent EDGAR filings; the October transactions were routine stock-award exercises and tax-withholding sales by the Senior VP and Controller and Treasurer, with significance scores of 1. The signal from the insider register is absence, not conviction.
The next event that matters is the Q3 print on October 20. The question for that day is whether supply chain progress at Pratt, Raytheon award momentum, and any update to full-year free cash flow guidance can justify the gap between $183 and a consensus target that has not materially moved despite six weeks of stock price weakness.
See the live data behind this article on ORTEX.
Open RTX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
